Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-048818

Chief Executive Officer sold 58,765 shares at an average $8.81 ($517,442)

  • Chief Executive Officer acquired 31,250 shares (option exercise)
  • Chief Executive Officer acquired 25,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Gibson Christopher · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-06 Exercise or conversion : show line 1 in the form +31,250 $2.48 $77,500 905,056 D
2023-09-06 Sale : show line 2 in the form −33,765 $8.78 $296,575 871,291 D
2023-09-06 Conversion : show line 3 in the form +4,000 4,000 I
2023-09-06 Sale : show line 4 in the form −4,000 $8.83 $35,335 0 I
2023-09-06 Conversion : show line 5 in the form +20,000 20,000 I
2023-09-06 Sale : show line 6 in the form −20,000 $8.83 $176,696 0 I
2023-09-06 Conversion : show line 7 in the form +1,000 1,000 I
2023-09-06 Sale : show line 8 in the form −1,000 $8.84 $8,836 0 I
Open-market sales · 58,765 sh · avg $8.81 · $517,442

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-06 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −31,250 $2.48 2030-12-30 31,250 500,000 D
2023-09-06 Conversion : show line 10 in the form Class B Common Stock −4,000 $0.00 4,000 523,000 I
2023-09-06 Conversion : show line 11 in the form Class B Common Stock −20,000 $0.00 20,000 448,000 I
2023-09-06 Conversion : show line 12 in the form Class B Common Stock −1,000 $0.00 1,000 120,875 I
Loading xslF345X05/doc4.xml…